Predictive Oncology Director Receives 64,680 RSUs, Increasing Holdings to 83,993

Rhea-AI Filing Summary

Predictive Oncology director Nancy Chung-Welch received a grant of 64,680 restricted stock units (RSUs) on 09/09/2025. Each RSU converts to one share of common stock upon vesting and the award vests in full on October 31, 2025, subject to continued service through that date. The transaction is reported as an acquisition at a $0.00 price, leaving Ms. Chung-Welch with 83,993 shares beneficially owned after the grant.

Positive

• Alignment with shareholders via equity-based compensation that vests over time
• Cash preservation because the award is equity (RSUs) granted at $0.00 rather than cash
• Clear vesting date provided: RSUs vest in full on October 31, 2025, subject to continued service

Negative

• None.

Insights

Financial Analyst

TL;DR: A routine director equity grant of 64,680 RSUs aligns executive incentives without immediate cash outlay.

The award represents compensation delivered as equity rather than cash, which preserves company cash while increasing potential share-based compensation expense when recognized. The full vest date of October 31, 2025 creates a time-based service condition; there are no performance conditions disclosed. For investors, this is a standard governance practice to align board members with shareholder interests, and the size of the grant should be considered relative to total shares outstanding to assess dilution, which is not provided in this filing.

Corporate Governance Expert

TL;DR: Typical single-date RSU grant to a director; transparency is adequate but limited to vesting terms.

The Form 4 discloses the grant amount, vesting date, and that each RSU converts to one share, which meets disclosure norms under Section 16. The absence of performance criteria suggests a straightforward service-based retention award. The filing does not provide any details about total equity pool or board compensation policy, so governance context is incomplete from this document alone.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CHUNG-WELCH NANCY

(Last) (First) (Middle)

C/O PREDICTIVE ONCOLOGY INC.

91 43RD STREET SUITE 110

(Street)

PITTSBURGH PA 15201

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Predictive Oncology Inc. [ POAI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/09/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/09/2025		A		64,680(1)	A	$0.00	83,993	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The grant consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs shall vest in full on October 31, 2025, subject to continued service through the applicable vesting date.

	/s/Josh Blacher, Attorney-in-Fact	09/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did POAI director Nancy Chung-Welch receive?

She received 64,680 restricted stock units (RSUs), each representing one share of common stock upon vesting.

When do the RSUs granted to Nancy Chung-Welch vest?

The RSUs vest in full on October 31, 2025, subject to continued service through that date.

How many shares does Nancy Chung-Welch beneficially own after the grant?

Following the reported transaction, she beneficially owns 83,993 shares.

Was there a purchase price for the RSU grant?

The transaction is reported with a price of $0.00, indicating a compensatory grant rather than a purchase.

What type of filing reported this transaction?

This transaction was reported on a Form 4 under Section 16 disclosure requirements for insiders.